Infections in bone marrow transplant recipients.
D000212:Acyclovir / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000150:complications; D006098:Granulocytes / Q000637:transplantation; D006561:Herpes Simplex / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D017053:Infection Control; D007239:Infections / Q000188:drug therapy; D007372:Interferons / Q000627:therapeutic use; D007422:Intestines / Q000382:microbiology; D010356:Patient Isolation; D010406:Penicillins / Q000627:therapeutic use; D011014:Pneumonia / Q000517:prevention & control; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage; D014916:Whole-Body Irradiation / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D007166:Immunosuppressive Agents; D010406:Penicillins; D014765:Viral Vaccines; D007372:Interferons; D000212:Acyclovir